Clarithromycin: Immunomodulatory therapy of experimental sepsis and acute pyelonephritis by Escherichia coli
Authors:
- Evangelos J. Giamarellos-BourboulisEGEvangelos J. Giamarellos-Bourboulis
- Theodoros AdamisTATheodoros Adamis
- Lambros SabracosLSLambros Sabracos
- Maria RaftogiannisMRMaria Raftogiannis
- Fotini BaziakaFBFotini Baziaka
- Thomas TsaganosTTThomas Tsaganos
- Pantelis KoutoukasPKPantelis Koutoukas
- Diamantis PlachourasDPDiamantis Plachouras
- Panayotis E. KarayannacosPKPanayotis E. Karayannacos
- Helen GiamarellouHGHelen Giamarellou
- 1 January 2005
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 37 (1) , 48-54
Abstract
The potency of clarithromycin as immunomodulator was assessed in an experimental model of sepsis based on acute pyelonephritis by susceptible Escherichia coli. 55 rabbits were utilized; 5 for preliminary pharmacokinetic study and 50 for treatment. The latter were divided into 5 groups of treatment, A: controls; B: clarithromycin pretreatment; C: amikacin pretreatment; D: clarithromycin treatment on presentation of pulmonary oedema; and E; amikacin treatment on presentation of pulmonary oedema. Survival was recorded; tumour necrosis factor-alpha (TNFalpha), and malondialdehyde (MDA) were estimated in serum; activities of caspase-3 in monocyte cytosolic extracts were studied; and bacterial counts made in various organs. Median survival of animals of groups A, B, C, D and E was 1.0, 21.0, 12.5, 2.0 and 5.0 d, respectively. TNFalpha and MDA and monocyte caspase-3 activity of group A increased over time; no increases were detected in groups B and C. Concentrations of MDA and activities of monocytic caspase-3 were decreased after administration of clarithromycin in group D, an effect not occurring in group E. Bacterial load was decreased in renal tissue of group D compared to group A. It is concluded that intravenous clarithromycin might constitute a promising immunomodulator in sepsis even in the advent of pulmonary oedema.Keywords
This publication has 9 references indexed in Scilit:
- Possible role of increased oxidant stress in multiple organ failure after systemic inflammatory response syndromeCritical Care Medicine, 2003
- Role of Apoptotic Cell Death in SepsisScandinavian Journal of Infectious Diseases, 2003
- Fourteen-Member Macrolides Promote the Phosphatidylserine Receptor-Dependent Phagocytosis of Apoptotic Neutrophils by Alveolar MacrophagesAntimicrobial Agents and Chemotherapy, 2003
- Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-kappaB transcription factorsJournal of Antimicrobial Chemotherapy, 2002
- In vivo efficacy of continuous infusion versus intermittent dosing of ceftazidime alone or in combination with amikacin relative to human kinetic profiles in a Pseudomonas aeruginosa rabbit endocarditis modelJournal of Antimicrobial Chemotherapy, 2001
- Immunological therapy of sepsis: experimental therapiesIntensive Care Medicine, 2001
- Protective effects of anti‐C5a peptide antibodies in experimental sepsisThe FASEB Journal, 2001
- Interleukin 8 Receptor Deficiency Confers Susceptibility to Acute Experimental Pyelonephritis and May Have a Human CounterpartJournal of Experimental Medicine, 2000
- Dose‐dependent inhibition of cell proliferation induced by lipid peroxidation products in rat hepatoma cells after enrichment with arachidonic acidLipids, 1999